Oxcarbazepine
NDC 27241-237, Oxcarbazepine, tablet, extended release, from Ajanta Pharma USA Inc..
- Product NDC
- 27241-237
- Status
- Listed
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217659
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27241-237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE150 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27241-237-01 | 27241023701 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-237-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d947e9b1-2a15-4048-bb4e-fe56b6851848NADAC price for package 27241023701
GET /v1/drugs/nadac/27241023701
Use it
Look up 27241-237 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27241-237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27241-237. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.